WALTHAM, Mass. (AP) _ ImmunoGen Inc. (IMGN) on Friday reported a loss of $24.1 million in its first quarter.On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 10 cents.The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 21 cents per share.The drug developer posted revenue of $38.1 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $24.3 million.ImmunoGen expects full-year revenue in the range of $75 million to $85 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMGN at https://www.zacks.com/ap/IMGN